Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
69.1M
-
Number of holders
-
181
-
Total 13F shares, excl. options
-
53.3M
-
Shares change
-
-1.91M
-
Total reported value, excl. options
-
$1.39B
-
Value change
-
-$64.4M
-
Put/Call ratio
-
0.74
-
Number of buys
-
109
-
Number of sells
-
-74
-
Price
-
$26.13
Significant Holders of Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT) as of Q1 2022
219 filings reported holding HCAT - Health Catalyst, Inc. - Common Stock, par value $0.001 per share as of Q1 2022.
Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT) has 181 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 53.3M shares
of 69.1M outstanding shares and own 77.11% of the company stock.
Largest 10 shareholders include BlackRock Inc. (4.64M shares), VANGUARD GROUP INC (4.24M shares), ALLIANCEBERNSTEIN L.P. (3.84M shares), WELLINGTON MANAGEMENT GROUP LLP (3.67M shares), Capital Research Global Investors (3.39M shares), FMR LLC (2.95M shares), Clearbridge Investments, LLC (2.32M shares), abrdn plc (1.44M shares), JANUS HENDERSON GROUP PLC (1.3M shares), and RIVERBRIDGE PARTNERS LLC (1.22M shares).
This table shows the top 181 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.